1 / 12

HYPERTENSION IN PREGNANCY LEADING CAUSE OF MATERNAL DEATH AND

HYPERTENSION IN PREGNANCY LEADING CAUSE OF MATERNAL DEATH AND PERINATAL MORTALITY / MORBIDITY BP MONITORING IS MAJOR ACTIVITY OF ANTENATAL CARE AFFECTS UP TO 10 % OF ALL PREGNANCIES. 75 70. wks. 40. 0. TERMINOLOGY. korotkofF V normal pregnancy. dbs.

amiel
Download Presentation

HYPERTENSION IN PREGNANCY LEADING CAUSE OF MATERNAL DEATH AND

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HYPERTENSION IN PREGNANCY LEADING CAUSE OF MATERNAL DEATH AND PERINATAL MORTALITY / MORBIDITY BP MONITORING IS MAJOR ACTIVITY OF ANTENATAL CARE AFFECTS UP TO 10 % OF ALL PREGNANCIES

  2. 75 70 wks 40 0 TERMINOLOGY korotkofF V normal pregnancy dbs ABNORMAL VALUES ? > 140 / 90 ( NELSON) DBP > 90 two readings systolic rise > 30 or diastolic > 15 PROTEINURIA > 0 . 3 GM IN 24 HOURS

  3. CLASSIFICATION PREGNANCY INDUCED HYPERTENSION DEVELOPING AFTER 20 / 40 PREVIOUSLY NORMOTENSIVE PROTEINURIC PIH ( PRE - ECLAMPSIA) > 0 . 3 G / 24 HR CHRONIC HYPERTENSION DIAGNOSED BEFORE OR DURING PREGNANCY - essential - renal disease - phaeo / conn’s - coartation CHRONIC HYPERTENSION WITH SUPERIMPOSED PRE – ECLAMPSIA ECLAMPSIACONVULSION DURING PREGNANCY OR WITHIN 7 DAYS OF DELIV., NOT CAUSED BY EPILEPSY

  4. PET AETIOLOGY GLYCEROPHOSPHOLIPIDS ARACHIDONIC ACID CYCLO OXYGENASE ASPIRIN PROSTAGLANDINS THROMBOXANES PROSTACYCINS ? IMMNUNOLOGIC MECHANISMS

  5. PET RISK FACTORS PRIMIGRAVIDA OR NEW PARTNER AGE RACE LOW SOCIAL CLASS FAMILIAL TREND ? SINGLE GENE UNDERLYING HYPERTENSIVE DISORDER 20 % DIABETES 50 % TWINS ( MONO) 30 % HYDATIDIFORM MOLE PREVIOUS PET 30 %

  6. SEVERE ( FULMINATING ) PET DBP > 110 WITH PROTEINURIA SYMPTOMSHEADACHE VISUAL SPOTS EPIGASTRIC PAIN VOMITING HYPER - REFLEXIA

  7. head ache

  8. PET MANAGEMENT MILD - MONITOR, DELIVER NEAR TERM MODERATE - FETUS MATURE, DELIVER - FETUS IMMATURE, MONITOR MOTHER LFT URIC ACID, BUN CREATININE CLEARANCE COAGULATION SYMPTOMS BABY BIOPHYSICAL GROWTH DOPPLER NST

  9. ANTIHYPERTENSIVES LONG TERM METHYL DOPA LABETOLOL ATENOLOL NIFEDIPINE HYDRALLAZINE ACUTE HYDRALLAZINE SODIUM NITRO – PRUSSIDE LABETOLOL

  10. ANTICONVULSANTS PROPHYLAXIS MAGNESIUM SULPHATE PHENYTOIN DIAZEPAM TREATMENT DIAZEPAM

  11. ECLAMPSIA Rx Control airway Stop convulsion reduce BP Deliver ( GA C. Section) watch postnatally † FROM BRAIN HEMORRHAGE AND 60 % HAVE LIVER DYSFUNCTION

  12. PREDICTION OF PET RISK FACTORS ROLL OVER TEST OF GANT ANGIOTENSION II PRESSOR TEST URIC ACID COAGULATION FACTORS SERUM RHUBARB DOPPLER ULTRASOUND

More Related